Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by torpedomanon May 04, 2017 7:33pm
175 Views
Post# 26206079

RE:RE:RE:RE:RE:Financing, etc

RE:RE:RE:RE:RE:Financing, etcTo buy or not?
Not a chance I would buy RVX shres at this junture. It is high high risk now for sure. Despite what Sarah says. I believe the Dart/Citibank loan is due around the first week of Aug. l have lost track of the loan value - I think it is well over $ 25,000,000
If I were Dart  I would be ready to pull the plug. It has taken way too long and I would own the IP/patents. I don't need Don and his people. I have billions and that will buy a lot of knwledge, expertise and exposure.
Maybe that exposure would be with BP. I could sell it to Pfizer or AZ or Merck or any of the big boys and name my price IF they were interested..
I have been in RVX since 2004 and kept the faith for all these years.I am not even sure BP is really all that interested in what is a very disruptive technology. I keep thinking " Whats wrong with this picture?

To sell or not?????

Torpedoman 
 
Bullboard Posts